Tuberculosis screening, isoniazid preventive therapy coverage and factors associated with active TB diagnosis among people living with HIV at public health facilities of central Ethiopia
Guardat en:
| Publicat a: | PLoS One vol. 20, no. 3 (Mar 2025), p. e0319676 |
|---|---|
| Autor principal: | |
| Altres autors: | , , , , |
| Publicat: |
Public Library of Science
|
| Matèries: | |
| Accés en línia: | Citation/Abstract Full Text Full Text - PDF |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
MARC
| LEADER | 00000nab a2200000uu 4500 | ||
|---|---|---|---|
| 001 | 3175933150 | ||
| 003 | UK-CbPIL | ||
| 022 | |a 1932-6203 | ||
| 024 | 7 | |a 10.1371/journal.pone.0319676 |2 doi | |
| 035 | |a 3175933150 | ||
| 045 | 2 | |b d20250301 |b d20250331 | |
| 084 | |a 174835 |2 nlm | ||
| 100 | 1 | |a Aboma, Mecha | |
| 245 | 1 | |a Tuberculosis screening, isoniazid preventive therapy coverage and factors associated with active TB diagnosis among people living with HIV at public health facilities of central Ethiopia | |
| 260 | |b Public Library of Science |c Mar 2025 | ||
| 513 | |a Journal Article | ||
| 520 | 3 | |a IntroductionTB is the most frequent opportunistic infection and cause of death among People living with HIV/AIDS. Human immunodeficiency virus-positive individuals are routinely screened for tuberculosis as a means of monitoring efforts to mitigate the consequences of the disease on HIV-positive patients. TB status assessment identifies HIV-positive clients who show no evidence of active TB by symptom screening and would benefit from treatment with isoniazid for prevention of TB disease among HIV positives.MethodsA facility-based cross-sectional study design was conducted in public health facilities of West Shewa Zone from January to February 2019. Of the 28 Public health facilities providing HIV/AIDS care and support (HCT and ART services) 13 of them were selected by simple random sampling techniques. Finally, 815 study participants were recruited by systematics sampling techniques & proportional sample size allocation was applied depending on the HIV patient load in each health facility. After reviewing relevant literature, a structured questionnaire adapted from standardized WHO guidelines, prepared for monitoring & evaluation of TB/HIV activities was used to collect data via interviewer.ResultsOf the total, 769 (94.4%) PLHIV were screened for tuberculosis, among which 212 (27.6%) were found to be positive for active tuberculosis. Among 557 (72.4%) individuals eligible for IPT, only 300 (53.9%) were provided IPT; 257 (46.1%) eligible PLHIV were not provided IPT. Resident (adjusted odds ratio [AOR] 5.6), those who didn’t attend school (AOR 4.0), primary school (grade 1-8) (AOR 3.2), and secondary school (grade 9-12) (AOR 4.2) were significantly associated with the likelihood of tuberculosis infection.ConclusionThe present study findings demonstrated that tuberculosis screening for PLHIV at West Shewa Zone public health facilities was improved in comparison with reports from many African countries and other parts of Ethiopia. The IPT implementation rate fell short of both national and WHO guidelines, notwithstanding this improvement. In the study area, diagnostic methods for tuberculosis and existing preventive measures should be improved overall. | |
| 651 | 4 | |a Africa | |
| 651 | 4 | |a Ethiopia | |
| 653 | |a Infections | ||
| 653 | |a Public health | ||
| 653 | |a Guidelines | ||
| 653 | |a Regression analysis | ||
| 653 | |a Isoniazid | ||
| 653 | |a Mortality | ||
| 653 | |a Telemedicine | ||
| 653 | |a Questionnaires | ||
| 653 | |a Health facilities | ||
| 653 | |a Disease prevention | ||
| 653 | |a Monitoring | ||
| 653 | |a Random sampling | ||
| 653 | |a Sampling techniques | ||
| 653 | |a Tuberculosis | ||
| 653 | |a Human immunodeficiency virus--HIV | ||
| 653 | |a Opportunist infection | ||
| 653 | |a Antiretroviral therapy | ||
| 653 | |a Patients | ||
| 653 | |a Sample size | ||
| 653 | |a Health care facilities | ||
| 653 | |a Systematics | ||
| 653 | |a Acquired immune deficiency syndrome--AIDS | ||
| 653 | |a Sampling methods | ||
| 653 | |a Health care | ||
| 653 | |a Statistical sampling | ||
| 653 | |a Data collection | ||
| 653 | |a Teenagers | ||
| 653 | |a Social | ||
| 700 | 1 | |a Abdisa, Bayisa | |
| 700 | 1 | |a Imana, Gudata | |
| 700 | 1 | |a Taye, Kefyalew | |
| 700 | 1 | |a Gonfa Moti | |
| 700 | 1 | |a Fufa, Merob | |
| 773 | 0 | |t PLoS One |g vol. 20, no. 3 (Mar 2025), p. e0319676 | |
| 786 | 0 | |d ProQuest |t Health & Medical Collection | |
| 856 | 4 | 1 | |3 Citation/Abstract |u https://www.proquest.com/docview/3175933150/abstract/embedded/L8HZQI7Z43R0LA5T?source=fedsrch |
| 856 | 4 | 0 | |3 Full Text |u https://www.proquest.com/docview/3175933150/fulltext/embedded/L8HZQI7Z43R0LA5T?source=fedsrch |
| 856 | 4 | 0 | |3 Full Text - PDF |u https://www.proquest.com/docview/3175933150/fulltextPDF/embedded/L8HZQI7Z43R0LA5T?source=fedsrch |